Aurora Sterilisation, founded in 2019 and headquartered in France, is making significant technological advancements in the Biopharma and Health Care industries. With the tagline "Bringing the highest sanitary safety and environmental quality for medical devices," the company emphasizes its commitment to innovation and safety in medical equipment sterilization.
At the heart of their innovation is the Aqsaniit, claimed to be the first non-toxic low temperature plasma sterilator designed for both medical and research purposes. This product can eliminate -6log micro-organisms within 60 minutes at a maximal temperature of 40°C, utilizing a patented sterile bag, promising a safer and more environmentally sustainable alternative.
The company's last significant financial influx was a €3.00M Venture Round secured on 10 December 2021, backed by prominent investors like Go Capital, Normandie Participations, and Normandie Business Angels. This backing highlights strong confidence in Aurora Sterilisation's potential to transform sterilization practices in healthcare.